Comparing Ocrelizumab to Interferon/glatiramer Acetate in People with Multiple Sclerosis over Age 60
MULTIPLE SCLEROSIS JOURNAL（2024）
Key words
ocrelizumab,multiple sclerosis,elderly,comparative efficacy,MSBase
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined